After the market, VNDA investors experienced "Christmas in May"!! VNDA announced that the US Food and Drug Administration (FDA) has granted marketing approval of Fanapt(NYSE:TM) (iloperidone) for the acute treatment of adult patients with schizophrenia.
VNDA closed at just +1.08 today. It jumped to almost $10 in the after-hours trading. Its trading volume was 1.3 million shares during the day, more than 6 times the 10-day volume and more than 10 times the 90-day volume. Even in the after-hours trading, more than half-a-million shares traded!
VNDA's all-time high was $32/share set back in January 2007. This stock could have more room to go up, even after an +800% rise!
Good night and HappyTrading! ™
Disclosure: VNDA none